ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.350
-0.060 (-4.26%)
Apr 1, 2025, 4:00 PM EDT - Market closed

ADC Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Cash & Equivalents
250.87278.6326.44466.54439.2
Upgrade
Cash & Short-Term Investments
250.87278.6326.44466.54439.2
Upgrade
Cash Growth
-9.95%-14.66%-30.03%6.23%280.09%
Upgrade
Accounts Receivable
20.3225.1872.9730.22-
Upgrade
Other Receivables
---1.931.7
Upgrade
Receivables
20.3225.1872.9732.141.7
Upgrade
Inventory
18.3916.1812.0711.12-
Upgrade
Prepaid Expenses
8.3710.3423.515.358.16
Upgrade
Other Current Assets
9.455.99-0.021.4
Upgrade
Total Current Assets
307.39336.29434.98525.18450.45
Upgrade
Property, Plant & Equipment
13.4316.1310.2611.234.76
Upgrade
Long-Term Investments
-1.657.6141.2447.91
Upgrade
Other Intangible Assets
---12.9510.18
Upgrade
Long-Term Deferred Tax Assets
--37.126.05-
Upgrade
Long-Term Deferred Charges
---0.63-
Upgrade
Other Long-Term Assets
1.160.710.90.690.4
Upgrade
Total Assets
321.98354.78490.86617.97513.69
Upgrade
Accounts Payable
18.0315.5712.3512.085.28
Upgrade
Accrued Expenses
49.8239.1451.9337.7727.4
Upgrade
Current Portion of Long-Term Debt
---13.393.63
Upgrade
Current Portion of Leases
1.371.471.11.031
Upgrade
Current Income Taxes Payable
---3.750.15
Upgrade
Other Current Liabilities
11.2511.516.565.922.98
Upgrade
Total Current Liabilities
80.4767.6781.9473.9440.44
Upgrade
Long-Term Debt
433.73416.3322.07305.8234.78
Upgrade
Long-Term Leases
810.186.566.992.47
Upgrade
Long-Term Unearned Revenue
---23.5423.54
Upgrade
Other Long-Term Liabilities
0.477.690.7937.9573.43
Upgrade
Total Liabilities
524.62503.03411.41451.88178.19
Upgrade
Common Stock
8.437.317.316.456.31
Upgrade
Additional Paid-In Capital
1,2841,1811,166981.83981.06
Upgrade
Retained Earnings
-1,493-1,335-1,095-924.89-694.86
Upgrade
Treasury Stock
-0.22-0.54-0.68-0.13-0
Upgrade
Comprehensive Income & Other
-1.42-0.091.82102.8343
Upgrade
Shareholders' Equity
-202.64-148.2579.45166.09335.51
Upgrade
Total Liabilities & Equity
321.98354.78490.86617.97513.69
Upgrade
Total Debt
443.09427.95329.73327.2341.87
Upgrade
Net Cash (Debt)
-192.22-149.35-3.29139.32397.32
Upgrade
Net Cash Growth
----64.94%259.50%
Upgrade
Net Cash Per Share
-1.98-1.83-0.041.826.07
Upgrade
Filing Date Shares Outstanding
99.0882.5380.6476.8176.72
Upgrade
Total Common Shares Outstanding
98.8682.2980.6476.8176.72
Upgrade
Working Capital
226.92268.62353.04451.25410.01
Upgrade
Book Value Per Share
-2.05-1.800.992.164.37
Upgrade
Tangible Book Value
-202.64-148.2579.45153.14325.33
Upgrade
Tangible Book Value Per Share
-2.05-1.800.991.994.24
Upgrade
Machinery
6.525.944.684.152.54
Upgrade
Construction In Progress
----0.07
Upgrade
Leasehold Improvements
3.873.952.082.250.75
Upgrade
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q